0.2958
+0.0332
+(12.64%)
At close: April 17 at 9:52:10 PM GMT+2
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 2UV.BE | -- | -- | -- | -- |
| S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
| Downgrade | William Blair: Outperform to Market Perform | 12/23/2024 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 12/20/2024 |
| Downgrade | UBS: Buy to Neutral | 12/2/2024 |
| Maintains | Citigroup: Buy to Buy | 11/29/2024 |
| Maintains | Baird: Outperform to Outperform | 11/29/2024 |
| Downgrade | RBC Capital: Outperform to Sector Perform | 11/29/2024 |
Related Tickers
NBTX Nanobiotix S.A.
3.2900
-0.30%
SLRN Acelyrin, Inc.
2.2000
0.00%
KYTX Kyverna Therapeutics, Inc.
1.8600
+1.64%
HRTX Heron Therapeutics, Inc.
1.8400
0.00%
VYGR Voyager Therapeutics, Inc.
3.1600
+0.96%
GOSS Gossamer Bio, Inc.
0.8425
+1.49%
IBRX ImmunityBio, Inc.
2.4700
-0.40%
TNXP Tonix Pharmaceuticals Holding Corp.
15.71
-0.95%